University of Missouri School of Medicine MU Health School of Medicine
News Divider
            


Lesa Beamer, PhD, and Steven Van Doren, PhD, use MU's 800 MHz NMR spectrometer, the second of its generation in the U.S. and the only one in Missouri, for their enzyme research.


Biochemists Peer into Enzyme that Makes Bacteria Hazardous to Patients


New $1.04 million grant and large NMR spectrometer support chemical reaction research

Scientists know that enzymes function as catalysts for chemical reactions, but much about the internal machinery of enzymes remains a mystery. Now, a $1.04 million grant from the National Science Foundation will help MU biochemists Lesa Beamer, PhD, and Steven Van Doren, PhD, explore the pathways and networks in one enzyme that could play a role in preventing bacteria from infecting patients with weakened immune systems.

"We have known for a long time that enzymes are complicated, but studying their complexity has been difficult because the technology wasn't available until now," said Beamer, an associate professor of biochemistry. "Thanks to MU's recent investment in scientific resources, we have all of the right tools here to study the movements of these enzymes, as well as to attract external grant funding for our research."

Using a $2.1 million nuclear magnetic resonance (NMR) spectrometer installed at MU in 2008, Beamer and Van Doren hope to generate new insights about the internal functions of the phosphomannomutase/phosphoglucomutase (PMM/PGM) enzyme as it interacts with sugar molecules. The second of its generation installed in the U.S. and the only one in Missouri, MU's 800-megahertz NMR spectrometer offers one of only a few methods available for examining the three-dimensional structure of molecules. The NMR is in a $10 million medical research building that opened two years ago.

Beamer and Van Doren's research findings could aid in the development of new types of antibiotics, since the enzyme being studied, PMM/PGM, is produced by the bacteria Pseudomonas aeruginosa. The bacteria can grow in the body, in soil and on multiple surfaces and can cause severe infections in patients with underlying medical problems like cystic fibrosis.

"If scientists have a better understanding of this enzyme, then there's a better possibility of building a drug to stop the enzyme from working," said Van Doren, a professor of biochemistry. "The bacteria uses the enzyme in a pathway to create a system of defense, so if the enzyme can't work, then bacteria could be easier to eradicate in a clinical setting."

Beamer and Van Doren's study of how enzyme structures move and fluctuate, and how the timing of such activity affects an enzyme chemical reaction, is regarded as a promising new area of research.

"Our peers are calling this research transformative, and we are encouraged by that designation," Beamer said. "We believe that our research, using this level of detail, could change the way we think about not only this protein but also other enzymes and their biological systems."
MU Health Magazine

Divider

News and Events

Evans Evans Named Associate Dean and Chief Academic Officer for Springfield Clinical Campus
Role is to engage Columbia and Springfield leaders to provide strategic direction and vision
Robin Kruse, PhD Lack of Research Keeps End-of-Life Care in Status Quo
MU researcher finds only 10 clinical trials conducted in hospices since 1985, says more studies could improve patient care

Govindarajan MU Neurologist Earns National Education Honor
Raghav Govindarajan, MD, to receive National Golden Apple Award for Teaching Excellence

David Beversdorf Blood Pressure Medicine May Improve Conversational Skills of Individuals with Autism
Propranolol found to boost performance on six key components of communication

HMI Health Management and Informatics Professor Leads Largest Health Survey in Missouri
MU research center receives $2.13 million grant to survey more than 52,000 Missourians
Kattesh Katti, PhD MU Radiology Professor Named India’s Person of the Year in Science
Katti honored for breakthrough research in nanomedicine and green nanotechnology
Frederick Fraunfelder, MD Chickenpox, Shingles Vaccine May Cause Corneal Inflammation in Some Patients
Primary care physicians should be aware of possible vision side effect for susceptible patients
Infant-friendly Flu Vaccine Infant-friendly Flu Vaccine Developed with Key Protein
Natural additive offers protection against flu for babies younger than six months
Rural Area Medical School Program Addresses Rural Physician Shortage
Service learning enhances medical training, may increase rural practitioners




Media Relations
University of Missouri Health System
One Hospital Drive, DC028.00
Columbia, MO 65212
24/7 on-call pager: (573) 876-0708

Mary Jenkins
jenkinsmg@health.missouri.edu
(573) 882-7299

Jeff Hoelscher
hoelscherj@health.missouri.edu
(573) 884-1608

Derek Thompson
thompsonder@health.missouri.edu
(573) 882-3323

Diamond Dixon
DixonDi@health.missouri.edu
(573) 884-7541

Justin Kelley (Photographer)
kelleyju@health.missouri.edu
(573) 882-5786
Pager (573) 397-9289


Web Communications
University of Missouri Health System
One Hospital Drive, MA204G, DC018.00
Columbia, MO 65212
(573) 884-0298

Jennifer Orford
orfordj@health.missouri.edu
(573) 882-0298

Jesslyn Chew
chewj@missouri.edu
(573) 884-2891

Velvet Hasner
hasnerv@health.missouri.edu
(573) 884-1115

Justin Willett
willettj@health.missouri.edu
(573) 884-7740



Printer Friendly
Follow us on Twitter!   Facebook   YouTube Videos   Instagram   Pinterest  
Website created and maintained by the Office of Communications. Contact the MU School of Medicine.
Revised: April 27, 2013 - Copyright © 2014 - Curators of the University of Missouri. All rights reserved. DMCA and other copyright information. An equal opportunity/access/affirmative action/pro-disabled and veteran employer.